At a glance
ClinicalIndex Comparison RecordN/ACompleted· 58,303 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Long-term Active Surveillance Study for Oral Contraceptives (LASS)
Center for Epidemiology and Health Research, Germany·observational·Posted May 12, 2008·Updated Nov 19, 2014
In Brief
An observational study for Arterial Thromboembolism and 2 related conditions. Completed, enrolled 58,303 participants across 1 site.
Detailed Summary
The objective of this study is to characterize and compare the risks of long-term use of oral contraceptives containing drospirenone and of other established oral contraceptives.
Study Details
Timeline
N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2001
First PostedMay 2008
Primary CompletionMar 2011
Study CompletionDec 2011
TodayJul 2026
First PostedMay 12, 2008
Enrollment StartFeb 1, 2001
Primary CompletionMar 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 10.1 yearsPosted 18.1 years ago